0001193805-15-001993.txt : 20151204 0001193805-15-001993.hdr.sgml : 20151204 20151204160543 ACCESSION NUMBER: 0001193805-15-001993 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151202 FILED AS OF DATE: 20151204 DATE AS OF CHANGE: 20151204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC. CENTRAL INDEX KEY: 0001368514 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 562590442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O ADMA BIOLOGICS, INC. STREET 2: 465 STATE ROUTE 17 CITY: RAMSEY STATE: NJ ZIP: 07446 BUSINESS PHONE: (201) 478-5552 MAIL ADDRESS: STREET 1: C/O ADMA BIOLOGICS, INC. STREET 2: 465 STATE ROUTE 17 CITY: RAMSEY STATE: NJ ZIP: 07446 FORMER COMPANY: FORMER CONFORMED NAME: R&R ACQUISITION VI, INC DATE OF NAME CHANGE: 20060707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman Jerrold B CENTRAL INDEX KEY: 0001542519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36728 FILM NUMBER: 151270149 MAIL ADDRESS: STREET 1: 65 COMMERCE WAY CITY: HACKENSACK STATE: NJ ZIP: 07601 4 1 e614333_4-jgrossman.xml OWNERSHIP DOCUMENT X0306 4 2015-12-02 0 0001368514 ADMA BIOLOGICS, INC. ADMA 0001542519 Grossman Jerrold B C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 1 0 0 0 Common Stock, $0.0001 par value per share 2015-12-02 4 P 0 6000 9.1601 A 56058 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.145 to $9.20 per share. The reporting person undertakes to provide to ADMA Biologics, Inc., any security holder of ADMA Biologics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on December 2, 2015. 38,294 of these shares are held by the Genesis Foundation, an entity for which Jerrold Grossman has the power to vote and dispose of the shares of common stock of ADMA Biologics, Inc. On October 21, 2015, the reporting person resigned as the managing member of Maggro, LLC. Therefore, as of October 21, 2015 the reporting person is no longer the beneficial owner of 528,016 shares of the Issuer's Common Stock held by Maggro, LLC. The reporting person disclaims beneficial ownership of the Issuer's Common Stock held by Maggro, LLC, except to the extent of his nominal pecuniary interest therein. /s/ Jerrold B. Grossman 2015-12-04